Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Diabetes
100%
Therapeutic Response
100%
Sulfonylurea
100%
Pharmacogenetics
100%
Cellular Physiology
100%
Hepatic nuclear Factor
100%
Nuclear Factor I
100%
KATP Channel
40%
Molecular Genetics
40%
Cell Defects
40%
Glycemic Control
40%
Monogenic Diabetes
40%
Genetic Etiology
40%
Genetic Knowledge
20%
Insulin
20%
ATP Concentration
20%
Glucose Sensing
20%
Type 2 Diabetic Patients
20%
Oral Hypoglycemic Agents
20%
SUR1
20%
Response to Treatment
20%
Insulin Secretion
20%
High Dose
20%
Low-dose Insulin
20%
Early-onset Diabetes
20%
Underlying Etiologies
20%
Fasting Hyperglycemia
20%
Endocrine Cells
20%
Glucokinase mutation
20%
Pancreatic Development
20%
Exocrine Cells
20%
Insulin Requirement
20%
Pancreatic Stem Cells
20%
Genetic Classification
20%
Exocrine Dysfunction
20%
Genetics of Diabetes
20%
Biochemistry, Genetics and Molecular Biology
Cell Function
100%
Genetics
100%
Sulfonylurea
100%
Pharmacogenetics
100%
Nuclear Factor I
100%
Insulin
60%
Adenosine Triphosphate
40%
Molecular Genetics
40%
Glycemic Control
40%
Adenosine Triphosphate Sensitive Potassium Channel
40%
Glucokinase
20%
Hyperglycemia
20%
Sulfonylurea Receptor
20%
Low Drug Dose
20%
Drug Megadose
20%
Kir6.2
20%
Insulin Release
20%
Stem Cell
20%
Factor I Deficiency
20%
Glucose
20%
Pharmacology, Toxicology and Pharmaceutical Science
Sulfonylurea
100%
Pharmacogenetics
100%
Nuclear Factor I
100%
Insulin
80%
Etiology
60%
Adenosine Triphosphate
40%
Adenosine Triphosphate Sensitive Potassium Channel
40%
Hyperglycemia
20%
Tablet
20%
Diabetes Mellitus
20%
Sulfonylurea Receptor 1
20%
Deterioration
20%
Oral Antidiabetic Agent
20%
Glucokinase
20%
Glucose
20%
Low Drug Dose
20%
Neuroscience
Cell Function
100%
Genetics
100%
Sulfonylurea
83%
Nuclear Factor I
83%
Insulin
66%
Adenosine Triphosphate Sensitive Potassium Channel
33%
Adenosine Triphosphate
33%
Glucokinase
16%
Hyperglycemia
16%
Diabetes Mellitus
16%
Stem Cell
16%
Kir6.2
16%
Sulfonylurea Receptor 1
16%
Glucose
16%